A class-action suit alleges St. Louis health giant Ascension shared private patient records with Google, claiming violations of federal privacy rules and seeking class relief.

Long Island scientists are growing patient 'avatars' — organoids — to test dozens of drug combinations. Early trials show promise but wider validation and faster methods are still needed.

The FTC is requiring Ascension to divest seven ambulatory surgery centers in five metros before its $3.9B AmSurg acquisition can close.

WashU neurologist Tim Miller co‑led long‑term tofersen trials that show stabilization or improvement for some SOD1‑ALS patients — a milestone for a rare genetic form. The result reflects decades of antisense work at WashU.

Washington University researchers David Holtzman and Randall Bateman will be honored for developing the PrecivityAD blood tests that make Alzheimer’s diagnosis earlier and more accessible.

WashU’s Olin School will debut a two‑semester MS in AI for Business and a $10,000 scholarship aimed at workers affected by automation, while the university points to expanded financial aid. The program and aid are being pitched as quicker, cheaper routes into AI jobs.

An 80-foot blue whale skeleton and a full-scale heart model arrive at the Saint Louis Science Center this weekend. The traveling exhibition runs through Jan. 10, 2027.

A production‑representative MQ‑25 Stingray finished a two‑hour flight out of MidAmerica Airport, bringing Boeing's new Mascoutah plant a step closer to full production. The test validated autonomous controls and sets up further Navy trials.

SSM Health’s SLU Hospital has begun offering CYTALUX, an FDA‑cleared fluorescent injection that helps surgeons spot lung tumors during surgery. Trial data show it can reveal lesions missed by standard inspection.

Peter H. Raven, who guided the Missouri Botanical Garden for nearly four decades and built its global research reach, died April 25 at age 89.

SmartAsset ranks Missouri No. 7 for AI prevalence — 25.6% of workers use AI and the state has roughly 230 AI/data‑center jobs per 100,000 residents.

St. Charles-based D2 Solutions bought Florida’s ProModRx and says the acquisition will expand its UltraTouch offerings — and nearly double hiring in St. Charles.

BioSTL is facing a funding squeeze in its 25th year as institutional donors pull back while early‑stage deal flow in St. Louis surges. The nonprofit is seeking new donors and structures to keep startups moving.